Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Article Type
- Review1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Drugs1
Search Results
Sort by
- BookConstantine Mavroudis, Carl Lewis Backer, editors ; illustrations by Rachid F. Idriss.Contents:
Cannulation Techniques
Palliation Techniques
Patent Ductus Arteriosus
Vascular Rings, Tracheoplasty and Pulmonary Artery Sling
Coarctation of the Aorta/ Interrupted Aortic Arch
Interrupted Aortic Arch Repair, Type B
Atrial Septal Defect, PAPVR, and Scimitar
Ventricular Septal
Atrioventricular Canal Defect
Truncus Arteriosus
Aortopulmonary Window
Tetralogy of Fallot
Pulmonary Atresia with VSD
Double Outlet Ventricles
Transposition of the Great Arteries
Congenitally Corrected Transposition of the Great Arteries
Bidirectional Glenn and Fontan Operations
Fontan Revision and Arrhythmia Surgery
Arrhythmia Surgery
Ebstein?s Anomaly
Left Ventricular Outflow Tract Obstruction
Norwood Operation
Aortic-Left Ventricular Tunnel
Mitral Valve Repairs
Total Anomalous Pulmonary Venous Repair
Cor Triatriatum
Sinus of Valsalva Aneurysm
Coronary Artery Anomalies
Cardiac Transplantation
Selected Complications. - ArticleDeykin D.Drugs. 1977 Jan;13(1):46-51.Heparin remains the most effective antithrombotic drug. It acts by combining with plasma antithrombin, thereby accelerating the neurtalisation of thrombin and other acitvated coagulation factors. Full-dose intravenous heparin is indicated in all cases of pulmonary embolism and established deep venous thrombosis, unless there exist compelling contraindications. Continuous intravenous infusion of heparin appears to be safer than intermittent injection. Low-dose subcutaneous heparin is effective in preventing the initial occurrence of thigh vein thrombi and in reducing the incidence of fatal pulmonary embolism in general surgical patients over the age of 40. The efficacy of low-dose heparin in preventing pulmonary emboli following hip surgery has not been established. The incidence of severe heparin-induced thrombocytopenia appears to be rising. Platelet counts should be performed in all patients receiving heparin by any mode of administration.